Accessibility Menu
LifeVantage logo

LifeVantage

(NASDAQ) LFVN

Current Price$6.19
Market Cap$78.22MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2004)-71%
5 Year-0%
1 Year-50%
1 Month-6%
LifeVantage last closing stock price
MetricPriceDate
Last closeUSD 6.202026-07-15
LifeVantage stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.64%USD 6.242026-07-08
1 month-6.2%USD 6.612026-06-15
3 month+36.53%USD 4.542026-04-16
Year to date+2.28%USD 6.062025-12-31
1 year-49.8%USD 12.352025-07-15
3 year+55.61%USD 3.982023-07-14
5 year-0.19%USD 6.212021-07-16
Since inception-70.5%USD 21.022004-10-06

LifeVantage Financials at a Glance

Market Cap

$78.22MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$195.32M

Net Income (TTM)

$5.75M

EPS (TTM)

$0.44

P/E Ratio

13.94

Dividend

$0.19

Beta (Volatility)

0.76 (Low)

Price

$6.19

Volume

122,663.497

Open

$6.14

Previous Close

$6.18

Daily Range

$6.00 - $6.27

52-Week Range

$3.90 - $15.00

Estimated Earnings Date

Sep 3, 2026

LFVN News

Foolcom-Featured.png

LifeVantage Posts 13% Revenue Gain in Q4

Motley Fool Markets TeamSep 5, 2025

LifeVantage Launches $40 Million Dutch Auction Stock Buyback Program

Eric VolkmanSep 24, 2013

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About LifeVantage

LifeVantage makes supplements and wellness products for people and pets. Its main products help support daily health, energy, and skin care. Customers use these to manage stress, digestion, and aging concerns.

What’s in the Bottle? (Products and Services)

  • Nutrigenomic Supplements: Products like Protandim target cell health and stress for adults.
  • Digestive Health: ProBio and pre- and pro-biotics support gut health for general consumers.
  • Weight Management: PhysIQ line offers products for weight control and metabolism support.
  • Energy and Focus: Axio drink mixes and nootropics aim to boost mental clarity and energy.
  • Skin and Hair Care: TrueScience line includes anti-aging creams and shampoos for daily use.
  • Pet Supplements: Petandim helps manage oxidative stress in dogs.

Growth Moves: The LifeVantage Playbook

  • Launched MindBody GLP-1 System in the U.S. (2024) and Japan (2025).
  • Expanded product bundles and “stacks” to increase order size in 2024-2025.
  • Entered new international markets, including the Philippines and Taiwan, in 2025.
  • Adapted compensation plans for consultants in Asia and Europe in 2025.
  • Continued product innovation with new launches in multiple regions since 2024.

Why LifeVantage Stands Out (Without the Hype)

LifeVantage sells mainly through independent consultants and online channels, reaching customers in over 20 countries. Its focus on nutrigenomics—using nutrition to influence gene activity—sets it apart in the supplement market. The company’s product bundles and global direct sales network support its international growth.

Five Things You Need to Know

  • Revenue was $58 million in QQ1 2026, up 23.8% from QQ1 2025.
  • Gross profit margin reached 81.0% in QQ1 2026, up from 78.9% last year.
  • Americas revenue was $48.2 million and Asia/Pacific & Europe revenue was $10.2 million in the three months ended March 31, 2025.
  • Active accounts grew 10.2% year-over-year to 140,000 as of March 2025.
  • Operating income was $4 million in QQ1 2026, up 57.7% from QQ1 2025.

Bottom Line

LifeVantage has grown by expanding its product lines and global reach. Its direct selling model and focus on science-based wellness products drive its business evolution.

AI Generated • Apr 16, 2026

Industry

Personal Products

Sector

Consumer Staples

Employees

238

CEO

Steven R. Fife, CPA

Website

www.lifevantage.com

Headquarters

Lehi, UT 84043, US

LFVN Financials

Key Financial Metrics (TTM)

Gross Margin

78.14%

Operating Margin

3.37%

Net Income Margin

2.94%

Return on Equity

17.78%

Return on Capital

26.34%

Return on Assets

9.26%

Earnings Yield

7.17%

Dividend Yield

2.98%

Payout Ratio

39.66%

Stock Overview

Market Cap

$78.22MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

12.62M

Volume

122.66K

Avg. Volume

483.08K

Financials (TTM)

Gross Profit

$152.62M

Operating Income

$6.58M

EBITDA

$9.59M

Operating Cash Flow

$6.51M

Capital Expenditure

-$2.73M

Free Cash Flow

$3.78M

Cash & ST Invst.

$12.48M

Total Debt

$10.21M

LifeVantage Performance Analysis

LifeVantage annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30USD 206,360,000N/A
20232023-06-30USD 213,398,0003.4%
20242024-06-30USD 200,164,000-6.2%
20252025-06-30USD 228,530,00014.2%
LifeVantage sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-06-30-5.7%
Q12025-09-30-13.7%
Q22025-12-312.9%
Q32026-03-31-10.7%
LifeVantage annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30USD 0.24N/A
20232023-06-30USD 0.20-15.3%
20242024-06-30USD 0.2311.9%
20252025-06-30USD 0.76233.8%
LifeVantage sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-06-30-42.3%
Q12025-09-3013.3%
Q22025-12-31-87.2%
Q32026-03-31406.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$43.72M

-25.2%

Gross Profit

$34.54M

-27.0%

Gross Margin

79.02%

N/A

Market Cap

$78.22MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$328.65K

N/A

Employees

238

N/A

Net Income

$1.36M

-60.7%

EBITDA

$2.37M

-52.4%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

$12.48M

-42.2%

Total Debt

$10.21M

-20.1%

Accounts Receivable

$4.62M

+121.4%

Inventory

$18.38M

+5.2%

Long Term Debt

$8.32M

-23.5%

Short Term Debt

$1.89M

-0.1%

Return on Assets

9.26%

N/A

Return on Invested Capital

15.66%

N/A

Free Cash Flow

$3.98M

+109.6%

Operating Cash Flow

$4.99M

+123.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CHGGChegg, Inc.
$0.78-6.84%
WYHGWing Yip Food Holdings Group Limited American Depositary Shares
$4.84+3.20%
BRIDBridgford Foods Corporation
$6.37-2.52%
HAINThe Hain Celestial Group, Inc.
$0.58-1.04%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$15.60-0.00%
ATAIAtaiBeckley
$7.15+0.33%
ONDSOndas
$6.65-0.06%
INTCIntel
$96.98-0.06%

Questions About LFVN

What is the current price of LifeVantage?

LifeVantage is trading at $6.18 per share.

What is the 52-week range for LifeVantage?

Over the past 52 weeks, LifeVantage has traded between $3.90 and $15.00.

How much debt does LifeVantage have?

As of the most recent reporting period, LifeVantage reported total debt of $10.21M.

How much cash does LifeVantage have on hand?

LifeVantage reported $12.48M in cash and cash equivalents in its most recent financial results.

What is LifeVantage’s dividend yield?

LifeVantage currently has a dividend yield of 2.98%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services